P

Inventor

TACK JOHANNES

DE11 patents
⚠️ This page may combine multiple inventors who share the name “TACK JOHANNES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

6 patents
US5676968AOct 14, 1997

Transdermal therapeutic systems with crystallization inhibitors

SCHERING AG162 citations98
US5730954AMar 24, 1998

Preparation comprising cavitate- or clathrate-forming host/guest complexes as contrast agent

SCHERING AG42 citations92
US5798338AAug 25, 1998

Solid dosage forms that contain clathrates of 17α-ethinyl estradiol

SCHERING AG47 citations91
US5286494AFeb 15, 1994

Medicinal agents with sustained action

SCHERING AG27 citations86
US7087078B2Aug 8, 2006

Tubular vascular implants (stents) and methods for producing the same

SCHERING AG15 citations79
US5432170AJul 11, 1995

Process for the production of semisolid preparations containing micronized active ingredients

SCHERING AG5 citations54

INHALE THERAPEUTIC SYST

1 patent
US6294204B1Sep 25, 2001

Method of producing morphologically uniform microcapsules and microcapsules produced by this method

INHALE THERAPEUTIC SYST158 citations97

ACTIPAC BIOSYSTEMS GMBH

1 patent
US6572894B2Jun 3, 2003

Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process

ACTIPAC BIOSYSTEMS GMBH42 citations89

NEUROBIOTEC GMBH

1 patent
US7258871B2Aug 21, 2007

Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states

NEUROBIOTEC GMBH13 citations79

REITER RUDOLF

1 patent
US9695173B2Jul 4, 2017

Pharmaceutical compositions for the treatment of capillary arteriopathy

REITER RUDOLF0 citations49

BERLIREM GMBH

1 patent
US11046640B2Jun 29, 2021

Water-soluble L-DOPA esters

BERLIREM GMBH0 citations48